130 related articles for article (PubMed ID: 9415596)
61. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
Ludlow CL; Naunton RF; Fujita M; Sedory SE
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
[TBL] [Abstract][Full Text] [Related]
62. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
63. Botulinum toxin in the treatment of recalcitrant mutational dysphonia.
Woodson GE; Murry T
J Voice; 1994 Dec; 8(4):347-51. PubMed ID: 7858670
[TBL] [Abstract][Full Text] [Related]
64. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
[TBL] [Abstract][Full Text] [Related]
65. Three-dimensional reconstruction of immunolabeled neuromuscular junctions in the human thyroarytenoid muscle.
Sheppert AD; Spirou GA; Berrebi AS; Garnett JD
Laryngoscope; 2003 Nov; 113(11):1973-6. PubMed ID: 14603058
[TBL] [Abstract][Full Text] [Related]
66. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
[TBL] [Abstract][Full Text] [Related]
67. Increased acute and chronic mitotic activity in rat laryngeal muscles after botulinum toxin injection.
Inagi K; Connor NP; Schultz E; Ford CN; Cook CH; Bless DM; Heisey DM
Laryngoscope; 1998 Jul; 108(7):1055-61. PubMed ID: 9665256
[TBL] [Abstract][Full Text] [Related]
68. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
Genack SH; Woo P; Colton RH; Goyette D
Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
[TBL] [Abstract][Full Text] [Related]
69. Singer's dystonia: first report of a variant of spasmodic dysphonia.
Chitkara A; Meyer T; Keidar A; Blitzer A
Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
[TBL] [Abstract][Full Text] [Related]
70. The effect of botulinum toxin A on the vocal symptoms of spastic dysarthria: a case study.
McHenry M; Whatman J; Pou A
J Voice; 2002 Mar; 16(1):124-31. PubMed ID: 12002879
[TBL] [Abstract][Full Text] [Related]
71. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
Witsell DL; Weissler MC; Donovan MK; Howard JF; Martinkosky SJ
Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
[TBL] [Abstract][Full Text] [Related]
72. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
[TBL] [Abstract][Full Text] [Related]
73. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
Langeveld TP; Drost HA; Baatenburg de Jong RJ
Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
[TBL] [Abstract][Full Text] [Related]
74. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia.
Castellanos PF; Gates GA; Esselman G; Song F; Vannier MW; Kuo M
Laryngoscope; 1994 Jun; 104(6 Pt 1):656-62. PubMed ID: 8196438
[TBL] [Abstract][Full Text] [Related]
75. Botulinum toxin therapy for abductor spasmodic dysphonia.
Woodson G; Hochstetler H; Murry T
J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
[TBL] [Abstract][Full Text] [Related]
76. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
77. Histology of nerves and muscles in adductor spasmodic dysphonia.
Chhetri DK; Blumin JH; Vinters HV; Berke GS
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
[TBL] [Abstract][Full Text] [Related]
78. [Botulinum toxin in spasticity treatment].
Sławek J
Neurol Neurochir Pol; 1998; 32 Suppl 1():71-84. PubMed ID: 9608556
[TBL] [Abstract][Full Text] [Related]
79. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
80. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
